BRENNEN

Industries / Health / Medical supply distribution

Tracing drugs

Tracing drugs means keeping a record of each pack's path from its maker through wholesalers to the pharmacy or hospital, so that a fake, a theft or a bad batch can be found and stopped.

7

Milestones achieved, from 1988 to 2025.

2

To watch for: announced, not yet confirmed outside.

2

Open deliverables. Nobody has shipped them.

The road

AchievedWatch forOpen

Achieved

  1. 1988

    Sale histories for resellers

    The US Prescription Drug Marketing Act of 1987, signed on 22 April 1988, required wholesalers that were not a maker's authorized distributors, often called secondary wholesalers, to pass on a pedigree before each sale: a written history of the drug's earlier sales. Authorized distributors, which buy directly from makers, were exempt. FDA's rule setting out what a pedigree must hold, published on 3 December 1999, was delayed in 2000, 2003 and 2004 and took effect on 1 December 2006; that month a federal court in New York barred FDA from enforcing the parts that required a trace back to the maker and lot numbers, and the injunction was still in force in October 2010.

    Lessona paper record that left out the main channel took 18 years to come into force and was then blocked in court.

    fda.govgovinfo.govfda.gov

    Credit

    the US Congress; the FDA; RxUSA Wholesale, which brought the suit

  2. 2003

    A grand jury on fakes

    On 27 February 2003 Florida's Seventeenth Statewide Grand Jury reported on counterfeit drugs resold through the state's wholesale market. It asked for one standard pedigree form tracing every sale back to the maker, and felony charges for forging one or failing to provide one. A review by the Legislature's research office that month found 50 to 55 of Florida's 1,458 permitted drug wholesalers under suspicion of counterfeiting or diversion (moving drugs out of the channel they were sold into), and criminal cases up from almost none in the 1990s to more than 50 since 1999. Florida then tightened its pedigree rules in stages, with a wider requirement taking effect in July 2006.

    Lessoncounterfeiters forged the paper pedigrees themselves, so the papers alone could not show which stock was genuine.

    flsenate.govoppaga.fl.govpackworld.com

    Credit

    Florida's Seventeenth Statewide Grand Jury; OPPAGA, the Florida Legislature's research office

  3. 2004

    Radio tags by 2007

    In February 2004 an FDA task force on counterfeit drugs wrote that "the adoption and common use of reliable track and trace technology is feasible in 2007", that paper records are "more likely to be incomplete or falsified", and that radio-frequency identification (RFID), tags a reader detects by radio, "appears to be the most promising approach". Two years later, by Packaging World's account, Pfizer was the only drugmaker tagging a drug in commercial distribution apart from a few generic makers supplying Wal-Mart; Pfizer put the cost of tagging five Viagra pack types at $5 million, and the acting FDA commissioner said he was "disappointed at the apparent slowdown".

    Lessona date drawn from suppliers' forecasts, with no rule and no agreed tag standard behind it, did not arrive.

    webarchive.library.unt.edupackworld.com

    Credit

    the FDA Counterfeit Drug Task Force; Pfizer

  4. 2012

    Every handover recorded

    Turkey's İlaç Takip Sistemi (ITS, the drug tracking system) began in 2010 by checking each pack's DataMatrix code, a square barcode holding the product number, a serial number, the batch and the expiry date, at the point where it was dispensed. In 2012 a second phase made every actor in the country's regulated supply chain report each sale and purchase, and matched the two sides; a 2020 study calls it the first full track-and-trace system across a country's regulated drug supply chain. The main reason was reimbursement fraud: pharmacies were paid by sending in the barcodes cut from packs they sold, and printing houses made fake ones, a loss put at US$1 billion a year; the first software crashed soon after its 2010 launch and had to be rebuilt, and one wholesaler said it spent about 100 million Turkish lira to take part.

    Lessonthe authors credit its success to a single payer that paid pharmacies only for verified, scanned dispensing.

    pmc.ncbi.nlm.nih.gov

    Credit

    Turkey's Ministry of Health; studied by Koray Parmaksiz, Elizabeth Pisani and Maarten Olivier Kok (2020)

  5. 2016

    A tracing platform suspended

    In February 2016 China's drug regulator, the CFDA, suspended its electronic drug monitoring system, the Product Identification, Authentication and Tracking System, while it redrafted the rules for monitoring drug sales. The platform was run by Alibaba Health, which had its own online drug sales; the month before, the Hunan pharmacy chain Yontinhe Group had sued the CFDA, saying the operator could see "detailed sales data of drug industry competitors".

    Lessona national tracing database holds every seller's sales, so who runs it matters as much as the code on the pack.

    fortune.comglobaltimes.cn

    Credit

    the CFDA; Alibaba Health; Yontinhe Group, which brought the suit

  6. 2022

    Forged papers, real bottles

    In January 2022 a federal court in Brooklyn unsealed Gilead's suit against 22 defendants, among them the Maryland wholesale distributor Safe Chain Solutions, over counterfeit and tampered bottles of its HIV medicines Biktarvy and Descovy. Gilead said its investigation found 85,247 bottles worth more than $250 million that had been sold to pharmacies and passed to patients over two years; many had been bought from patients and resold with falsified documents. With US Marshals it seized stock and papers at 17 offices and warehouses in nine states: some bottles were genuine with faked papers or altered packaging, and others held painkillers or an antipsychotic instead of the HIV drugs. Safe Chain said it never knowingly sold counterfeits, and the court ordered the defendants to stop selling Gilead medicines.

    Lessongenuine bottles bought back from patients re-entered the licensed channel on forged papers, so a sale history on paper did not show where a drug had been.

    fiercepharma.com

    Credit

    Gilead's investigators; the US District Court for the Eastern District of New York

  7. 2025

    False alarms made rare

    Since 9 February 2019 pharmacies, hospitals and wholesalers in the EU scan a code on each prescription pack and check it against a shared database before passing it on. Seven months in, about 3% of all scans raised false alerts, from missing data, mismatched batches and scanner faults rather than fakes, by the European Medicines Verification Organisation's (EMVO's) count, and several member states had told staff receiving "unknown" errors to dispense anyway. By December 2025 the alert rate was 0.08%, across 31 countries and about 14 billion transactions a year, by EMVO's own figures; Finland's national system reported about 0.01% for 2025, one alert in 10,000 checks.

    Lessonan alarm that sounds on 3 genuine packs in 100 teaches staff to pass it by, so the system was useful against fakes only once its data were clean.

    gmp-compliance.orggmp-compliance.orgrm.coe.intlaakevarmennus.fi

    Credit

    EMVO and the national verification organizations, with the makers, wholesalers and pharmacies that cleaned their data

Watch for

  1. Pakistan codes every pack

    Pakistan's drug regulator, DRAP, made a DataMatrix code with a unique serial number mandatory on registered medicines made or imported from 9 October 2026, as the first phase of a national Pharmaceutical Track and Trace System; packs made before that date may still be sold. The health minister said the ministry had worked on it for about 18 months.

    Achieved whenan outside party, such as an auditor or a survey of pharmacies, reports that new packs carry working codes and that the system records their movement through distributors.

    en.dailypakistan.com.pk

    Claimed by

    DRAP and Pakistan's health ministry, October 2026

  2. Egypt issues the serials

    Egyptian Drug Authority decree No. 475 of 2025 requires imported finished medicines to be in a national track-and-trace system from 1 February 2026 and locally made or packed ones from 1 August 2026. The state system issues every serial number, companies may not make their own, and distributors must report shipping and receiving.

    Achieved whenthe authority or an outside party publishes counts of packs and distributor events recorded after the August 2026 deadline.

    vimachem.com

    Claimed by

    the Egyptian Drug Authority, in a 2025 decree as summarized by Vimachem, a software vendor

Open

  1. 01

    A forged-paperwork test set

    A public set of 300 made-up US drug sale records, in the forms wholesalers pass on with each sale (tracing event files and PDFs), about a third with planted faults of the kinds seen in real cases: a seller missing from licensing records, a pharmacy selling into the wholesale market, a lot the maker never shipped to the stated buyer, dates out of order. Score AI document reviewers and rule-based checkers on how many faults they catch and how many clean records they wrongly flag.

    The brief
    Credit · unclaimed
  2. 02

    Where fakes entered, coded

    A public table of every WHO Medical Product Alert about falsified medicines, coded for where the fakes were found or offered (licensed wholesaler, unauthorized distributor, hospital, pharmacy, online, informal market), with product, batch numbers, countries and dates, and yearly counts of alerts in which fakes reached hospitals or passed through licensed distributors.

    The brief
    Credit · unclaimed

Open 01 · the brief

A forged-paperwork test set

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

A public set of 300 made-up US drug sale records, in the forms wholesalers pass on with each sale (tracing event files and PDFs), about a third with planted faults of the kinds seen in real cases: a seller missing from licensing records, a pharmacy selling into the wholesale market, a lot the maker never shipped to the stated buyer, dates out of order. Score AI document reviewers and rule-based checkers on how many faults they catch and how many clean records they wrongly flag.

Why it is still open

Gilead's own investigation found its fakes, resold with falsified documents, only after 85,247 bottles had reached pharmacies and patients, and congressional staff in 2012 found leaks by reading 300 pedigree chains by hand. A Europe PMC search in November 2026 for counterfeit or suspect drugs together with sale histories and machine learning or language models returned blockchain designs, not a test of checking the documents themselves. The nearest public data, StanzaAPI's CC0 set of EPCIS 2.0 events (October 2026), holds made-up tracing records and a catalog of 11 hostile inputs, such as injected code, but no forged or inconsistent sale histories.

github.comfiercepharma.comoversightdemocrats.house.gov

Built with what exists

GS1's EPCIS 2.0, the event format many tracing systems use to share where a product has been; FDA's public search of wholesale distributors and third-party logistics providers by state licence; a language model such as Claude (the Note "Seven more flagged" covers a Claude-based reviewer of drug-making records); Python for the rule checks.

gs1.orgaccessdata.fda.gov

  1. First step

    Write 30 records by hand, plant 10 faults, and run one language model and one rule script over them.

  2. Done looks like

    300 records with an answer key checked by two people; at least three tools scored, each with the share of planted faults caught and the share of clean records flagged, by fault type; records, key and scores published under an open license.

Open 02 · the brief

Where fakes entered, coded

Credit · unclaimed

The first to publish is credited on this line, and the deliverable moves from Open to Achieved.

What to build

A public table of every WHO Medical Product Alert about falsified medicines, coded for where the fakes were found or offered (licensed wholesaler, unauthorized distributor, hospital, pharmacy, online, informal market), with product, batch numbers, countries and dates, and yearly counts of alerts in which fakes reached hospitals or passed through licensed distributors.

Why it is still open

WHO publishes each alert as a separate page. Its July 2026 alert on falsified Darzalex, a cancer medicine, says the fakes "were supplied or offered by non-authorized distributors and, in at least one case, hospitals received these falsified products". The nearest study, a 2025 systematic review by I. Fryze and B. D. Naughton, pooled recall data from regulators in 23 countries and did not code WHO's alerts by entry point; a Europe PMC search in November 2026 found no such coding. The closest tool, the Medicine Quality Monitoring Globe of the Infectious Diseases Data Observatory (IDDO), codes press reports by the outlet where products were found, including "Distributor/Wholesaler" and "Hospital pharmacy", but shows regulators' alerts, WHO's among them, only as links.

iddo.orgiddo.orgwho.intwho.intpmc.ncbi.nlm.nih.gov

Built with what exists

WHO's alert pages; a language model such as Claude or Gemini to draft the codes from each alert's text; a spreadsheet or small database; two people to check the codes.

  1. First step

    Code by hand the seven falsified-medicine alerts on WHO's list for 2025 and 2026, and compare them with a model's codes.

  2. Done looks like

    every falsified-product alert on WHO's full list coded with links; a second coder agrees on at least 90% of the supply-chain codes in a random 20%; yearly counts and the coding guide published.